文献速递头颈外科

头颈部癌症cN3病变患者临床结局的多中心研究

Multi-institutional study of clinical outcomes of patients with head and neck cancer presenting with cN3 disease.
PubMed 文献 · Head Neck · 2023-02-28

多中心回顾性研究纳入1996至2019年两家学术中心治疗的85例头颈部鳞状细胞癌临床N3病变患者,评估根治性放化疗的疾病控制、毒性和临床结局相关变量。中位随访2.8年,5年总生存率38%、区域控制率80%、无远处转移率80%,19%出现严重并发症。

要点

  • 头颈部鳞癌cN3患者根治性放化疗后5年区域控制率达80%。
  • 5年总生存率38%,无远处转移率80%。
  • 19%患者出现严重并发症,远处转移为常见失败模式。

核心结论

  • 对头颈部鳞状细胞癌临床N3病变患者,根治性放化疗可实现较好的区域控制。
  • 远处转移是常见失败模式,应作为前瞻性研究的重点。

研究设计与样本

  • 回顾性研究,纳入1996年至2019年在两家高收治量学术中心接受治疗的头颈部鳞状细胞癌临床N3病变患者。
  • 共纳入85例患者,中位随访2.8年。

主要发现

  • 5年总生存率为38%,5年区域控制率为80%,5年无远处转移率为80%。
  • 19%的患者出现严重并发症。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate disease control, toxicities, and variables associated with clinical outcomes for patients with head and neck squamous cell carcinoma and clinical N3 disease (HNSCC N3) treated with definitive chemoradiation therapy. METHODS: We performed a retrospective review of patients with HNSCC N3 treated at two high-volume academic centers between 1996 and 2019. RESULTS: We identified 85 patients with a median follow-up of 2.8 years. Five-year overall survival, regional control, and freedom from distant metastases rates were 38%, 80%, and 80%, respectively. Severe complications were identified in 19% of patients. CONCLUSIONS: Favorable regional control is achievable with definitive chemoradiation therapy for patients with HNSCC N3 disease. Distant metastases are a common pattern of failure and should be a focus of prospective study.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Witek ME, Morris CG, Alexander GS, et al. Multi-institutional study of clinical outcomes of patients with head and neck cancer presenting with cN3 disease. Head Neck. 2023. PMID: 36855018. doi:10.1002/hed.27326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。